Mid-Afternoon Market Update: Dow Tumbles 250 Points; Zynga Shares Spike Higher

Toward the end of trading Monday, the Dow traded down 0.70% to 35,978 while the NASDAQ fell 0.93% to 14,796.51. The S&P also fell, dropping, 0.72% to 4,643.29.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 61,263,030 cases with around 859,350 deaths. India confirmed a total of at least 35,708,440 cases and 483,930 deaths, while Brazil reported over 22,523,900 COVID-19 cases with 620,030 deaths. In total, there were at least 308,004,270 cases of COVID-19 worldwide with more than 5,507,340 deaths.


Leading and Lagging Sectors


Health care shares fell by just 0.4% on Monday. Meanwhile, top gainers in the sector included Olink Holding AB OLK, up 31% and RxSight, Inc. RXST up 38%.


In trading on Monday, consumer discretionary shares dipped by 2.6%.


Top Headline


AZZ Inc AZZ reported upbeat earnings for its third quarter on Monday.

AZZ posted quarterly earnings of $0.85 per share, beating analysts’ estimates of $0.82 per share. The company’s quarterly sales came in at $231.74 million, versus expectations of $238.63 million.

AZZ reaffirmed FY22 sales guidance of $865 million to $925 million. The company said it sees FY22 EPS of $3.00 to $3.20.

 

Equities Trading UP


RxSight, Inc. RXST shares shot up 37% to $12.25 after the company issued preliminary Q4 and FY21 guidance above estimates.


Shares of Zynga Inc. ZNGA got a boost, shooting 44% to $8.65 after the company announced it will be acquired by Take-Two Interactive Software in a cash and stock transaction valued at $9.86 per Zynga share, representing a total enterprise value of approximately $12.7 billion.


Olink Holding AB OLK shares were also up, gaining 31% to $15.31 after the company issued Q4 and FY21 sales guidance.


Check out these big movers of the day


Equities Trading DOWN

Citi Trends, Inc. CTRN shares tumbled 16% to $68.32. Citi Trends reported 2021 holiday sales results and updated long-term strategic plan.


Shares of Amicus Therapeutics, Inc. FOLD were down 24% to $7.25 after the company issued its preliminary and unaudited 2021 revenue, and full-year 2022 outlook and revenue guidance. Amicus Therapeutics said it sees FY21 Galafold sales of $306 million.


Rapid Micro Biosystems, Inc. RPID was down, falling 21% to $7.25. Rapid Micro Biosystems said it expects Q4 total revenue of between $4.7 and $5.2 million.


Commodities

In commodity news, oil traded down 0.7% to $78.38, while gold traded down 0.2% to $1,793.30.


Silver traded down 0.1% Monday to $22.38 while copper fell 1.2% to $4.3580.


Euro zone

European shares were lower today. The eurozone’s STOXX 600 dropped 1.48%, London’s FTSE 100 fell 0.53%, while Spain’s IBEX 35 Index fell 0.51%. The German DAX dropped 1.13%, French CAC 40 declined 1.44% and Italy’s FTSE MIB Index dropped 0.96%.

The unemployment rate in Italy dropped to 9.2% in November from 9.4% in the prior month.


Economics


US wholesale inventories rose 1.3% for November, versus analysts’ expectations for a 1.2% increase.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!